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Abstract: Historically, cobalt-chromium, stainless steel and titanium alloys have been the main principal materials used in a 
variety of medical procedures for load-bearing implants in the body. Magnesium and magnesium-based alloys have the potential 
to be used as short-term structural support during the healing process of damaged hard tissues and diseased bone. Unlike 
traditional biologically compatible metals, which are not biologically degradable, magnesium based alloys offer both biological 
degradability and biological absorbability. Despite the many advantages offered by magnesium, its rapid degradation rate in the 
highly aggressive and corrosive body fluid environment has severely limited its present day medical application. This article 
reviews the chemical immersion technique for producing calcium phosphate coatings on magnesium substrates for slowing down 
the degradation rate while maintaining the biological compatibility and absorbability. 
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1. Introduction 
Biologically compatible materials have been engineered 
into a variety of medical devices and implants to assist in 
healing, replace diseased tissues and in some drastic cases 
completely replace damaged tissues. The repair and 
replacement of diseased or damaged hard tissues presents a 
major challenge to patient health, wellbeing and quality of life. 
A major consequence of tissue damage or loss resulting from 
accidents or diseases is the psychological impact on patient 
wellbeing. For example, even minor injuries to fingers or toes 
that interfere with function and usually heal without much 
trouble can have a significant impact. While severe bone 
diseases and injuries that result in the loss of a limb creates 
functional problems for patients for many years. In many 
cases the device or implant is temporary and only needs to 
remain in the body during the healing process. Once the 
healing process is complete, a second surgical procedure is 
required to remove the device or implant which significantly 
increases patient site morbidity and associated health costs 
[1-3]. Alternatively, when an implant needs to remain in the 
body permanently, as in the case of a total joint replacement, 
long-term biocompatibility, mechanical strength and 
structural stability become important factors that must be 
addressed. 
Biologically compatible polymers have been extensively 
investigated since the 1950’s for a variety of potential tissue 
engineering applications. Natural polymers such as collagen 
[4, 5], chitosan [6, 7], hyaluronic based derivatives [8, 9], 
polysaccharides [10, 11], and a variety of protein based 
materials such as fibrin gel[12, 13] have all been extensively 
studied and found to be suitable for a wide range of tissue 
engineering applications. Synthetically manufactured 
biologically degradable and biologically absorbable polymers 
such as Poly (lactic acid), PLA [14, 15], Poly (L-lactic acid), 
PLLA [16, 17], Poly (lactic-co-glycolic acid), PLGA [18, 19], 
Poly-caprolactone PCL [20, 21] and Poly (glycolic acid) PGA 
[22, 23] have all being investigated and used in a variety of 
biomedical applications. For example, biodegradable sutures 
currently in clinical use are made from PLA and PGA. These 
have also been extensively investigated for the controlled 
delivery of drugs to specific organs within the body [24-26]. 
Advantages of using biological compatible polymers arise 
from their low toxicity within the body and the ability to 
8 Sridevi Brundavanam et al.:  Chemical Immersion Coatings to Improve Biological Degradability of Magnesium  
Substrates for Potential Orthopaedic Applications 
control their degradation rate. Furthermore, the by-products of 
degradation can be easily handled by the body’s natural 
processes and excreted in the urine [27]. Polymers can also be 
produced in a variety of shapes and structures such as disks, 
films, fibres and pellets to meet the specific requirements for a 
particular application. In addition, polymers can be produced 
with micrometre and nanometre scale typographical surface 
features to enhance cell-substrate interactions with the surface 
of the implant [28].  
Unfortunately, polymers with all their many advantages are 
limited by their low mechanical strength, which severely 
restricts their use in load bearing and hard tissue supporting 
applications. Metals have more desirable mechanical 
properties due to their relatively high strength, elastic modulus, 
fracture toughness and resilience and as a result several 
metallic biomaterials such as cobalt-chromium-based steel 
alloys, titanium-based alloys, nickel-based alloys and stainless 
steels have been widely used as implant materials [29-31]. 
However, studies have shown that conventional surgical metal 
alloys are not biologically absorbable and because of 
corrosion and wear, there is a release toxic metallic ions into 
surrounding cells and tissues [32-34]. These detrimental 
metallic ions induce an unfavourable inflammatory response 
from the body’s immune system and the surrounding tissues, 
which significantly reduces the biocompatibility of the 
implant [33]. Furthermore, the significant difference in 
mechanical properties between metal implants and 
surrounding bone tissue results in a clinical phenomenon 
known as stress shielding. For example, the elastic modulus of 
both cobalt-chrome alloys and stainless steel is approximately 
ten times larger than that of bone, while a titanium alloy such 
as Ti-6Al-4V is around five times greater [35]. Normally, bone 
tissues are constantly undergoing remodelling and 
modification in response to the stresses produced during 
everyday activities. However, the presence of a metal implant 
creates stress-shielding, which results in a major portion of the 
load been carried by the implant. Thus, with most of the load 
been carried by the implant, the surrounding bone tissues 
experience significantly less load related stress and as a result 
leads to bone resorption, mechanical instability and the 
ultimate failure of the implant [36]. In addition, metallic 
implants used as temporary structural supports, such as pins, 
screws, and plates often need to be removed by a second 
surgical procedure once the healing process has taken place. 
The increased health costs and morbidity associated with the 
second surgical procedure highlights the need for new 
biologically compatible materials that can provide short-term 
structural support during the healing process. Then after 
healing has taken place to an acceptable level, the material 
would then biologically degrade and safely be reabsorbed and 
metabolized by the body. 
One interesting alternative to conventional metals used as 
current bio-implants is magnesium. Magnesium (Mg) is a 
lightweight, silvery-white metal that has been extensively 
used in alloy form in a wide range of engineering applications 
such as aerospace and automotive [37]. The density of Mg and 




C, which is 1.6 and 4.5 
times less dense than aluminium and steel, respectively. 
Interestingly, the density of pure Mg is 1.74 g/cm
3
, while 
natural bone ranges from around 1.8 to 2.1 g/cm
3
 and the 
elastic modulus of Mg and human bone are 45 GPa and 40 to 
57 GPa respectively [38, 39]. It is because of the close 
similarity in the respective densities and elastic moduli that 
have made Mg a promising candidate for hard tissue 
engineering applications. The mechanical properties of Mg 
being similar to natural bone means that it has the potential to 
significantly reduce the possibility of stress shielding and 
prevent the associated bone resorption problems. Mg is also 
biologically degradable and biologically absorbable, with both 
Mg and its corrosions products considered physiologically 
beneficial, with as much as 30 g stored in the bone tissues and 
muscles of an adult body [40]. The body uses Mg, a bivalent 
ion, in a number of metabolic processes and to form apatite in 
the bone matrix [41]. And recent studies by Robinson et al. 
have shown that Mg has novel antibacterial properties against 
pathogens such as Escherichia coli, Pseudomonas aeruginosa 
and Staphylococcus aureus [42]. Because of these 
advantageous properties Mg has gained significant interest as 
a potential biologically degradable material that removes the 
need for additional surgeries to reclaim pins, screws, and 
plates used in the short term while the healing process takes 
place. Figure 1 presents an ideal life span of an Mg implant 
that slowly degrades and allows regenerating bone tissues to 
progressively carry the load.  The use of Mg as an implant 
material also has the potential to avoid the long-term 
complications associated with conventional metal implants in 
the body.  
 
Figure 1. Graphical representation of an ideal load carrying transition 
between a slowly degrading Mg implant and progressively regenerating bone 
tissue 
2. Biological Degradation of Magnesium 
The main limitation that prevents Mg being used in 
orthopaedic applications is its low corrosion resistance in 
body fluids, which are composed of water, dissolved oxygen, 
proteins and electrolytic ions such as chloride and hydroxide. 
In this highly corrosive aqueous environment results in the 
rapid release of ions from the metal surface which combine 
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with ions in the fluid to form chemical species, such as metal 
oxides, hydroxides, chlorides and other compounds [43]. 
Generally metals have a tendency to corrode in electrolytic 
environments with some metals having a greater propensity to 
degrade more rapidly than others as seen in Table 1.  
However, the interfacial region has also a significant bearing 
on the overall performance of metallic bio-implants. This can 
be shown in table The formation of metal oxides results in the 
creation of an oxide layer composed of Mg(OH)2 that adheres 
to the metal surface. The oxide layer is slightly soluble and 
reacts with chorine ions to form highly soluble magnesium 
chloride and the rapid production of hydrogen gas bubbles [44, 
45]. The localised formation of gas bubbles generally begins 
just after surgery and continues for periods as long as three 
weeks. During this post surgery period, the pH around the 
implant increases and results in alkalization of the surrounding 
tissue environment. The presence of hydrogen bubbles and 
local alkalization can severely affect pH dependent 
physiological processes in the vicinity of the implant and 
delay tissue healing [46]. However, the use of a subcutaneous 
needle can be used to prevent significant build up of gas 
around the implant. Furthermore, in his study Song has 
suggested that small hydrogen evolution rates of around 0.01 
ml/cm
2
/day can be easily handled by the human body and does 
not constitute a serious threat [47]. The high initial corrosion 
rate produces a thick oxide layer, which fully covers and seals 
the metal surface to form a passive layer, which physically 
stops or severely limits the migration of ionic species and 
hydrogen gas across the metal oxide solution interface. 
Unfortunately, the high corrosion rate during the first two to 
three weeks can cause a significant reduction in the 
mechanical and structural integrity of the implant before the 
bone tissues have had sufficient time to fully heal. 
Table 1. Electrochemical series of selected metallic ions and their voltage 
potential [78]  










In atmospheric air at room temperature Mg corrodes to 
form a thin grey oxide layer over its surface. The oxide layer 
then reacts with atmospheric moisture to form a more stable 
magnesium hydroxide [Mg(OH2)] and hydrogen gas 
[43].Under standard environmental conditions, the Mg(OH2) 
layer is able to provide some degree of protection and is also 
capable of slowing down the corrosion rate even under 
aqueous conditions [48]. When Mg is exposed to an aqueous 
environment the corrosion process can be expressed by the 
following equations. The primary anodic reaction involves 
metallic Mg being converted to Mg
2+
 ions as seen in equation 
(1), meanwhile the reaction occurring at the cathode, 
presented in equation 2, involves the reduction of protons.   
Anodic reaction: 
Mg → Mg2- + 2e-               (1) 
Cathodic reaction: 
2H2O + 2e
- → 2OH- + H2            (2) 
The general reaction of the overall corrosion process is 
represented by equation (3) below. 
Mg (s) + 2H2O (l) → Mg(OH)2 (s) + H2 (g)      (3) 
However, when Mg is exposed to chloride ions present in 
the physiological environment, the Mg(OH)2 interfacial layer 
reacts with the chloride ions to form highly soluble MgCl2. 
The high solubility of MgCl2 and the significant reduction in 
corrosion resistance provided by the reacting Mg(OH)2 layer 
results in rapid dissolution of the underlying Mg substrate and 
the formation of hydroxide ions and hydrogen gas [49]. The 
resulting dissolution and corrosion rate are import factors in 
the use of Mg as a biomaterial, since corrosion is likely to 
result in mechanical failure of an implant. Therefore, the 
corrosion rate must be taken into account when considering 
Mg and Mg based materials for hard tissue engineering and 
surgical applications. Ideally, the corrosion rate should be at a 
rate that allows temporary support of tissues during the 
recovery period. During the recovery period, initial 
mechanical strength would be maintained until the effects of 
corrosion start to occur. This would be followed by a gradual 
decrease in strength over the period of tissue recovery and 
finally the implant would be absorbed leaving the recovered 
tissues to carry the full load [50]. Other corrosion related 
factors that need to be considered is the increase in local pH 
and hydrogen evolution, both of which could have significant 
effects on tissues surrounding the implant. If Mg and Mg 
based materials are to be successfully used as an orthopaedic 
biomaterial, then the degradation behaviour and related 
factors of these materials need to be effectively controlled. 
3. Controlled Degradation Via Chemical 
Immersion Treatment 
In spite of magnesium’s many advantageous material 
properties, its high chemical reactivity and poor corrosion 
resistance has prevented its widespread use in orthopaedic 
applications. In general, materials used in orthopaedic 
application such as titanium alloys will only experience load 
induced stresses in the inner core of the implant, while its 
surface will be exposed and interact with the surrounding 
physiological environment. Because the interfacial properties 
between the implant surface and the physiological 
environment are very important, different processing 
techniques such as alloying, thermal spray coating, ion 
implantation, micro-arc oxidation, anodizing and surface 
coating treatments have been widely used to improve the 
biocompatibility of the underlying material [43, 51, 52]. In the 
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case of Mg, the processing techniques have primarily focused 
on improving the corrosion resistance of the metal when 
exposed to the biological environment [53, 54].   
Bioactive coatings such as calcium phosphate materials 
have been successfully applied to a variety of metallic 
implants in order to improve biocompatibility, promote 
attachment to surrounding hard tissues and to suppress the 
release of corrosion products into the human body [31]. 
Calcium phosphate (CaP) coating can be applied to a variety 
of substrate materials of varying sizes and shapes using a 
relatively straight forward technique known as chemical 
immersion [55, 56]. Apart from convincing experimental 
results of a number of independent studies that indicate CaP 
coatings can significantly improve corrosion resistance 
[57-59], the coatings also have the advantages of being 
non-toxic, display good biocompatibility and have enhanced 
bioactivity properties with respect to bone cells and other 
body tissues [60]. Despite these many advantages, a number 
of studies have also shown a number of shortcomings such as 
poor coating adherence, surface cracking and effective control 
of the CaP phases formed during immersion [54]. Regardless 
of these shortcomings, biologically mimicking CaP coating 
formed via the chemical immersion technique have the 
potential to control the corrosion rate and enhance the 
biocompatibility of Mg and Mg based alloys for orthopaedic 
applications. 
 
Figure 2. Magnesium substrate coated with a DCPD coating: (a) Optical 
microscopy image of surface coating and (b) Higher resolution field emission 
scanning electron microscopy micrograph showing plate-like surface 
structures present in the coating. 
The results of a number of recent studies have confirmed 
that CaP coatings were able to enhance the corrosion 
resistance and improve the biocompatibility of Mg and Mg 
based alloys [61-63]. For example, a study by Xu et al. using a 
chemical immersion based technique was able to form a 
brushite (CaHPO4.2H2O) surface coating on an Mg-Mn-Zn 
alloy substrate using an alkaline electrolyte. Regrettably, 
subsequent testing revealed that the coating was porous and 
failed to prevent corrosion of the substrate in a simulated body 
fluid. Nonetheless, the coating did significantly reduce the 
corrosion rate and provide some degree of protection against 
the simulated body fluid [64]. The study not only found 
improved corrosion resistance, but also found that the brushite 
layer improved biocompatibility, promoted bone formation 
and subsequently transformed into hydroxyapatite [Ca10(OH)2 
(PO4)6] (HAP) with time [65]. In another study, Wang et al. 
was able to produce a calcium-phosphate coating by 
immersing an Mg substrate into a solution containing Ca and P 
[Ca (NO3)2 and Na2HPO4] to form a di-calcium phosphate 
di-hydrate (DCPD) surface coating [56]. The surface coating 
of DCPD was effective in improving the corrosion resistance 
of the substrate for the first 21 days of immersion in a 
simulated body fluid. Figure 2 and the enlarged micrograph 
shown in Figure 3 reveal structures in a typical DCPD coating 
formed by a chemical immersion technique developed by the 
authors. In a novel chemical immersion technique, Yanovska 
et al. incorporated low magnetic fields into a one-step 
immersion method. During this process the Mg substrate was 
immersed into an aqueous electrolyte containing 
Ca(NO3)2.4H2O and Na2HPO4.12H2O. The influence of 
magnetic fields in orientating the crystals during the coating 
formation was investigated, along with the types of phases 
present. The technique produced coatings composed of DCPD 
and HAP phases, the coatings were found to enhance 
corrosion resistance and significantly reduced the degradation 
rate of the substrate [66]. For example, Figure 4 presents a set 
of representative potential-dynamic polarization curves 
showing the improvement in corrosion resistance of an Mg 
substrate after receiving a DCPD coating. The corrosion 
testing was carried out in a phosphate buffer saline (PBS) 
solution at 37 ºC as a first step in assessing the coating 
bioactivity. 
 
Figure 3. Enlarged field emission scanning electron microscopy micrograph 
showing the DCPD flower-like plate structures present in the coating. 
The use of HAP coatings has a number of advantages 
besides improving the corrosion resistance of Mg and Mg 
International Journal of Biomedical Materials Research 2014; 2(2): 7-14 11 
 
based alloys in the physiological environment. HAP is a major 
inorganic component found in natural bone tissues, therefore 
using HAP as a biological coating on Mg offers a number of 
attractive properties such as its good biocompatibility and 
bioactivity properties with respect to bone cells and other 
body tissues [67]. Other desirable properties include slow 
biodegradability in situ and its ability to promote 
osteoconductivity and osteoinductivity, which can accelerate 
the in-growth of surrounding tissues [68-70]. These properties 
are of particular importance in the case of bone tissue that are 
constantly being replaced and removed by bone cells such as 
osteoblasts and osteoclasts, via a process known as 
remodelling. Studies have also shown that HAP displays an 
excellent biocompatible response to soft tissue such as skin, 
muscle and gums [71]. However, due to its low mechanical 
strength HAP is restricted to low load bearing clinical 
applications. Typical examples include coating the surface of 
conventional metallic implants to improve their 
biocompatibility and bioactivity, bone augmentation, drug 
delivery, and as filler material for both bone and dental 
implants [72-76]. 
 
Figure 4. Polarization curves showing the improvement in corrosion 
resistance of an Mg substrate after receiving a DCPD coating. The testing 
solution used was a phosphate buffer saline solution at 37 ºC and a pH of 7.4 
HAP coatings can be directly deposited directly onto Mg 
substrates using chemical immersion techniques or by 
chemically converting modifying a pre-existing calcium 
phosphate coating. For example Tomozawa et al. have treated 
pure magnesium substrates with Calcium-EDTA and KH2PO4 
based solutions [77]. The solution concentrations were varied 
from 0.01 M/L to 0.25 M/L, while the treatment temperatures 
were varied from 313 K to 373 K. Optimisation of their 
immersion process revealed that by adjusting the 
concentration and thermal treatment time to 0.25 M/L and 2 h, 
respectively, dense rod-like HAP crystals grew along the 
c-axis. HAP formation produced a dense, crystalline and 
uniform coating without the formation of a Mg(OH)2 
intermediate layer. The HAP coating formed by this chemical 
immersion technique was found to be stable and capable of 
significantly improving the corrosion resistance of the Mg 
substrates. Alternatively, a two-step immersion technique can 
be adopted to synthesize HAP coating on an Mg substrate. 
During the first step a CaP coating is deposited onto the 
substrate. Then during the second step the process converts the 
calcium phosphate into HAP. For example, the authors have 
produced a dicalcium phosphate dehydrate (brushite DCPD) 
coating on Mg substrates from aqueous solutions containing 
Ca(NO3)2 and KH2PO4 at 298 K. During the second step 
DCPD coated substrates are immersed into a solution of 
sodium hydroxide (NaOH) at 80 ºC for 2 h. At the end of this 
low temperature thermal treatment the DCPD is converted to 
HAP. The authors are currently carrying out degradation 
studies to determine the corrosion resistance of DCPD and 
DCPD converted to HAP coatings, Figure 4. Preliminary 
results indicate that significant improvement in corrosion 
resistance can be achieved by applying CaP coatings to Mg 
substrates. The chemical immersion technique is a 
straightforward and economic technique for synthesizing CaP 
coatings such as HAP on magnesium substrates. The coatings 
produced by chemical immersion were capable of slowing 
down the degradation rate by significantly improving 
corrosion resistance of the coated substrate.  
4. Conclusion 
In recent years, there has been significant research into 
developing novel biologically absorbable materials for 
orthopaedic applications. Mg has demonstrated that it has 
some attractive properties and the potential to be used as a 
biologically degradable implant material. Mg is an extremely 
biocompatible material with mechanical properties similar to 
bone tissue. However, in spite of having good 
biocompatibility and bioactivity properties, Mg’s poor 
corrosion resistance to the physiological environment has 
prevented its successful use in orthopaedic applications. 
Chemical immersion is an economic, efficient and 
straightforward technique that offers a direct method of 
depositing CaP coatings such as DCPD and HAP on Mg 
substrates. Not only do CaP coatings have the potential to 
reduce the corrosive effects of the physiological environment, 
but they also offer the potential to significantly improve 
biocompatibility and promote bone formation at the surface of 
an Mg based implant. Coating Mg with a dense CaP layer that 
significantly reduces the corrosion rate makes this an 
attractive material for the manufacture of biodegradable 
orthopaedic implants. While a significant amount of research 
has been conducted in recent years investigating the potential 
medical use of Mg and commercially available Mg alloys, 
further research is needed to fully evaluate methods of 
reducing the degradation rate in the physiological 
environment. Chemical immersion is one method that has the 
potential to deliver CaP coated Mg based materials with the 
potential to be used in the manufacture of biodegradable 
implants. However, further research is needed to fully 
optimize the operational parameters of the chemical 
immersion technique so that there is greater control of the 
resulting coating properties. In addition, further in vitro and in 
vivo studies are needed to verify the mechanical integrity of 
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the coatings and their biological compatibility with bone 
tissues.  
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